Upcoming deadline: revance therapeutics, inc. investors with substantial losses have opportunity to lead class action lawsuit - rvnc

San diego, california--(newsfile corp. - january 24, 2022) -  robbins geller rudman & dowd llp announces that purchasers or acquirers of revance therapeutics, inc. (nasdaq: rvnc) securities between november 25, 2019 and october 11, 2021, both dates inclusive ("class period") have until february 8, 2022, to seek appointment as lead plaintiff in aramic llc v. revance therapeutics, inc., no. 21-cv-09585. commenced on december 10, 2021 in the northern district of california, the revance therapeutics...
RVNC Ratings Summary
RVNC Quant Ranking